JPM vs MGF
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
MGF presents a stable but stagnant profile, anchored by a Piotroski F-Score of 5/9 and a current price ($2.90) that sits below its Graham Number ($3.39) but above its growth-based intrinsic value ($2.01). While the trust appears undervalued from a book perspective (P/B 0.91), the financial health is undermined by a highly unsustainable dividend payout ratio of 144.60%. Technical trends are strictly bearish (0/100), and negative revenue growth suggests a lack of fundamental momentum despite slight earnings growth.
Compare Another Pair
Related Comparisons
JPM vs MGF: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and MFS Government Markets Income Trust (MGF) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.